Liu Hui, Shen Xudan, Yu Tunan, Wang Yifan, Cai Sheng, Jiang Xia, Cai Xiujun
Zhejiang Provincial Key Laboratory of Laparoscopic Technology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang University, Hangzhou, China.
Front Nutr. 2022 Aug 2;9:938356. doi: 10.3389/fnut.2022.938356. eCollection 2022.
Vitamin D is considered as a nutrient protecting individuals against an array of diseases based on observational studies. Such a protective effect, however, has not been demonstrated by randomized controlled trials. This study aims to explore a putative causal role of vitamin D in common diseases through a two-sample Mendelian randomization (MR) framework.
Circulating vitamin D was predicted by 41 genetic variants discovered in European populations. Common diseases were verified through two ways, using information from Japanese patients of Biobank Japan and using information from European patients of FinnGen project. We additionally validated the results by replacing vitamin D-associated instrumental variables (IVs) of European population with that of an independent Japanese population and of an independent Indian population. Inverse-variance weighted method was used as the primary analytical approach while a series of MR methods including MR-Egger regression, weighted median, maximum likelihood, MR-PRESSO and multivariate MR were adopted to guarantee MR model assumptions and to detect horizontal pleiotropy.
Genetically predicted vitamin D was significantly associated with an increased risk of Graves' disease (OR = 1.71, 95%CI: 1.25-2.33, = 0.001) and cataract (OR = 1.14, 95%CI: 1.03-1.28, = 0.016); while with a decreased risk of esophageal cancer (OR = 0.66, 95%CI: 0.46-0.93, = 0.019). This significant causal link between vitamin D and cataract was validated replacing IVs identified in the European population with those from Japanese population. No notable associations of vitamin D with other diseases were observed.
Our findings indicate a potential causal role of vitamin D in common diseases, which needs further validation.
基于观察性研究,维生素D被认为是一种能保护个体抵御一系列疾病的营养素。然而,这种保护作用尚未在随机对照试验中得到证实。本研究旨在通过双样本孟德尔随机化(MR)框架探索维生素D在常见疾病中的假定因果作用。
利用在欧洲人群中发现的41个基因变异预测循环维生素D水平。通过两种方式验证常见疾病,一种是利用日本生物银行日本患者的信息,另一种是利用芬兰基因项目欧洲患者的信息。我们还用来自独立日本人群和独立印度人群的维生素D相关工具变量(IVs)替换欧洲人群的IVs来验证结果。采用逆方差加权法作为主要分析方法,同时采用一系列MR方法,包括MR-Egger回归、加权中位数、最大似然法、MR-PRESSO和多变量MR,以确保MR模型假设并检测水平多效性。
基因预测的维生素D与格雷夫斯病风险增加显著相关(OR = 1.71,95%CI:1.25 - 2.33,P = 0.001)和白内障(OR = 1.14,95%CI:1.03 - 1.28,P = 0.016);而与食管癌风险降低相关(OR = 0.66,95%CI:0.46 - 0.93,P = 0.019)。用日本人群的IVs替换欧洲人群中确定的IVs后,验证了维生素D与白内障之间的这种显著因果联系。未观察到维生素D与其他疾病有显著关联。
我们的研究结果表明维生素D在常见疾病中可能具有因果作用,这需要进一步验证。